Ulcerative colitis: open trials in China

69 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07158242
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Hoffmann-La Roche
Children's Hospital, Zhejiang University School of Medicine, Hangzhou · Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai
Registry updated 2026-11-05
NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Trial Treatment · Phase 2 · Eli Lilly and Company
Changzhou Second People's Hospital, Changzhou · Chongqing General Hospital, Chongqing · The First Affiliated Hospital of Fujian Medical University, Fuzhou · Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou · First Affiliated Hospital of Kunming Medical University, Kunming · Jiangsu Province Hospital, Nanjing · The Affiliated Hospital of Qingdao University, Qingdao · Shengjing Hospital Of China Medical University, Shenyang · The Second Afilliated Hospital of Hebei Medical University, Shijiazhuang · Taian City Central Hospital, Taian · Wuhan Union Hospital, Wuhan · Wuxi People's Hospital, Wuxi
Registry updated 2026-11-04
NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Binzhou Medical University Hospital, Binzhou · Changzhou Second People's Hospital, Changzhou · Sichuan Provincial People's Hospital, Chengdu · Chongqing General Hospital, Chongqing · The First People's Hospital of Foshan, Foshan · The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou · Heilongjiang Provincial Hospital, Harbin · The First Affiliated Hospital of Anhui Medical University, Hefei · Huizhou Central People's Hospital, Huizhou · First Affiliated Hospital of Kunming Medical University, Kunming · Liaocheng People's Hospital, Liaocheng · Meihekou Central Hospital, Meihekou · The Affiliated Hospital of Qingdao University, Qingdao · Shanghai Pudong New District Zhoupu Hospital, Shanghai · Shanghai Tenth People's Hospital, Shanghai · Yuebei People's Hospital Guangdong, Shaoguan · Peking University Shenzhen Hospital, Shenzhen · The First Affiliated Hospital of Soochow University, Suzhou · Taian City Central Hospital, Taian · Renmin Hospital of Wuhan University, Wuhan · Wuhan Union Hospital, Wuhan · Zunyi Medical College - No.1 Affiliated Hospital, Zunyi
Registry updated 2026-11-04
NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
The Second Xiangya Hospital of Central South University, Changsha · Changzhou Second People's Hospital, Changzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · Huizhou Central People's Hospital, Huizhou · The Second Affiliated Hospital of Soochow University, Suzhou · The Second Affiliated Hospital YuYing Childens Hospital of Wenzhou Medical university, Wenzhou · Zhongshan Hospital Affiliated to Xiamen University, Xiamen · Affiliated Hospital of Jiangsu University, Zhenjiang
Registry updated 2026-11-04
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Capital Center For Children's health Capital Medical University, Beijing · Changzhou No 2 Peoples Hospital, Changzhou · The Childrens Hospital, Zhejiang University School of Medicine, Hangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Ruijin Hospital Shanghai Jiao Tong University, Shanghai · Shengjing Hospital Of China Medical University, Shenyang
Registry updated 2026-11-03
NCT07302360
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Research · Xian-Janssen Pharmaceutical Ltd.
Peking University People's Hospital, Beijing · Peking Union Medical College Hospital, Beijing · Changzhou No 2 Peoples Hospital, Changzhou · The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The Second Affiliated Hospital of Zhejiang University, Hangzhou · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing · Shenzhen Hospital of Southern Medical University, Shenzhen · The Second Hospital of Hebei Medical University, Shijiazhuang · Tianjin Medical University General Hospital, Tianjin
Registry updated 2026-11-03
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Peking University Third Hospital, Beijing · Beijing Friendship Hospital, Capital Medical University, Beijing · Peking Union Medical College Hospital, Beijing · China-Japan Friendship Hospital, Beijing · Changzhou No 2 Peoples Hospital, Changzhou · West China Hospital Si Chuan University, Chengdu · Chongqing General Hospital, Chongqing · The First People's Hospital of Foshan, Foshan · The First Affiliated Hospital of Fujian Medical University, Fuzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The second Affiliated Hospital of Guangzhou Medical University, Guangzhou · Sun Yat-sen University - The Sixth Affiliated Hospital Guangdong Gastrointestinal Hospital, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Anhui Medical University, Hefei · Huai'an 1st Hospital, Huai'an · Jinhua Municipal Central Hospital, Jinhua · Lanzhou University Second Hospital, Lanzhou · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · Ningbo Medical Center Lihuili Hospital, Ningbo · Ruijin Hospital Shanghai Jiao Tong University, Shanghai · The Second Hospital of Hebei Medical University, Shijiazhuang · Taihe Hospital, Shiyan · Second Affiliated Hospital, SooChow University, Suzhou · Zhongshan Hospital Xiamen University, Xiamen · The Second Affiliated Hospital of Zhengzhou University, Zhengzhou · Zhuzhou Central Hospital, Zhuzhou · Affiliated Hospital of Zunyi Medical University, Zunyi
Registry updated 2026-11-03
NCT07265570
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Trial Treatment · Phase 2 · InSilico Medicine Hong Kong Limited
Beijing Friendship Hospital, Capital Medical University, Beijing · Binzhou Medical University Hospital, Binzhou · The Third Xiangya Hospital of Central South University, Changsha · West China School of Medicine and West China Hospital, Sichuan University, Chengdu · Sichuan Provincial People's Hospital, Chengdu · The First Affiliated Hospital of Chongqing Medical University, Chongqing · The First Affiliated Hospital of Gannan Medical University, Ganzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · Guangzhou First People's Hospital, Guangzhou · The First Affiliated Hospital of University of South China, Hengyang · Huizhou First Hospital, Huizhou · The First Affiliated Hospital of Kunming Medical University, Kunming · Lishui Central Hospital, Lishui · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · Zhongda Hospital Southeast University, Nanjing · The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning · Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai · LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai · Shengjing Hospital Of China Medical University, Shenyang · The Second Hospital of Hebei Medical University, Shijiazhuang · Tai 'an City Central Hospital, Taian · First Hospital of Shanxi Medical University, Taiyuan · Tianjin People's Hospital, Tianjin · Meihekou Central Hospital, Tonghua · The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou · Renmin Hospital of Wuhan University, Wuhan · Xi'an Central Hospital, Xian · The First Affiliated Hospital of Xinxiang Medical University, Xinxiang
Registry updated 2026-10-29
NCT07755241
A Study of AC-101 Tablets in Patients With Ulcerative Colitis
Trial Treatment · Phase 2 · Accro Bioscience (Suzhou) Limited
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Registry updated 2026-10-28
NCT07900945
Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants
Trial Treatment · Phase 1 · Keymed Biosciences Co.Ltd
Tianjin Medical University General Hospital, Tianjin
Registry updated 2026-10-28
NCT06979336
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Trial Treatment · Phase 2 · Genentech, Inc.
Binzhou Medical University Hospital, Binzhou · The First Hospital of Jilin University, Changchun · Sichuan Provincial People's Hospital, Chengdu · The First Affiliated Hospital of Fujian Medical University, Fuzhou · The second Affiliated Hospital of Guangzhou Medical University, Guangzhou · The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou · Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou · Huizhou Municipal Central Hospital, Huizhou · The First Affiliated Hospital of Ningbo University, Ningbo · Renmin Hospital of Wuhan University, Wuhan · Zhongshan Hospital Xiamen University, Xiamen · The Second Affiliated Hospital of Zhengzhou University, Zhengzhou
Registry updated 2026-10-27
NCT07071519
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Trial Treatment · Phase 3 · AbbVie
The First Hospital of Jilin University - Changchun /ID# 279290, Changchun · Hunan Children's Hospital /ID# 278111, Changsha · Guangzhou Medical University Affiliated Women and Children's Medical Center /ID# 277962, Guangzhou · The Childrens Hospital of Zhejiang University School of Medicine /ID# 278815, Hangzhou · Sir Run Run Shaw Hospital of Zhejiang University School of Medicine /ID# 277994, Hangzhou · Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 278113, Shanghai · Henan Children's Hospital Zhengzhou Children's Hospital /ID# 278794, Zhengzhou
Registry updated 2026-10-27
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Changshu · Chengdu · Jinhua · Luoyang · Luzhou · Shanghai · Wuhan
Registry updated 2026-10-23
NCT07878026
Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)
Trial Treatment · Early phase 1 · Jinling Hospital, China
Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing
Registry updated 2026-10-22
NCT07726888
Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis
Research · Second Affiliated Hospital of Wenzhou Medical University
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou
Registry updated 2026-10-20
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Beijing · Chengdu · Guangzhou · Hefei · Huizhou · Kunming · Shanghai · Wuxi
Registry updated 2026-10-16
NCT07758101
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease
Trial Treatment · Phase 1 · Guangdong Hengrui Pharmaceutical Co., Ltd
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Registry updated 2026-09-25
NCT07814456
Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors
Trial Treatment · Phase 2 · First Affiliated Hospital of Kunming Medical University
Kunming Medical University First Affiliated Hospital, Kunming
Registry updated 2026-09-15
NCT07389824
Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.
Trial Treatment · Qin Yu
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-08-25
NCT07767370
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
Trial Treatment · Early phase 1 · The Second Hospital of Nanjing Medical University
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
Registry updated 2026-08-17
NCT07768254
A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis
Trial Treatment · Phase 1 · Helixon Biotechnology (Suzhou) Co., Ltd
The First Affiliated Hospital of Anhui Medical University, Hefei
Registry updated 2026-08-17
NCT07747155
A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Pyrotech Therapeutics, Inc.
Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Registry updated 2026-08-07
NCT07744646
Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis
Trial Treatment · Phase 1 · The First Affiliated Hospital of Anhui Medical University
The First Affiliated Hospital of Anhui Medical University, Hefei
Registry updated 2026-08-04
NCT07442045
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
Research · Sixth Affiliated Hospital, Sun Yat-sen University
The Sixth Affiliated Hospital, South China University of Technology City: Foshan, Foshan · The First People's Hospital of Foshan, Foshan · Foshan Fosun Chancheng Hospital, Foshan, Foshan · The second Affiliated Hospital of Guangzhou Medical University, Guangzhou · The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou · the Second Affiliated Hospital of Shenzhen University (People's Hospital of Shenzhen Bao'an District), Shenzhen
Registry updated 2026-07-31
NCT07111273
DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis
Research · Qilu Hospital of Shandong University
Shandong University, Jinan
Registry updated 2026-07-28

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error